COMMUNIQUÉS West-GlobeNewswire

Quotient Limited Recaps Recent Milestone Achievement and Updates on the Initial Serological Disease Screening CE Mark Submission, planned 2019 US Field Trials and Reports Record Financial Results
28/05/2019
CE mark received on the initial Immunohematology microarray in April 2019 2018 manufacturing site certification and MosaiQ™ device CE mark combine with the recent approval to permit commercialization Successful European [...]
Athersys to Participate in four Events at the International Society of Cell and Gene Therapy Conference
28/05/2019
Company taking active role with two podium presentations, panel participation and session chair CLEVELAND, May 28, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its participation in several [...]
Transactions in relation to share buyback program
28/05/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
Immunicum AB (publ) Announces Outcome of Subscription in Employee Incentive Program 2019/2022
28/05/2019
Press Release 28 May 2019 Immunicum AB (publ) Announces Outcome of Subscription in Employee Incentive Program 2019/2022 Immunicum AB (publ) announced today the completion of the subscription of options in the long-term [...]
OSE Immunotherapeutics to Present at 5th Annual Immuno-Oncology: BD&L and Investment Forum
28/05/2019
Forum to be held in Chicago, IL, on May 31, 2019 NANTES, France, May 28, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that Alexis Peyroles, chief executive officer, [...]
Herantis Pharma Plc shares subscribed with option rights
28/05/2019
Herantis Pharma Plc shares subscribed with option rights Herantis Pharma Plc Company release 28 May 2019 at 9:00am 32,000 new shares of Herantis Pharma Plc have been subscribed with option rights of the option programs [...]
Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever
28/05/2019
PRESS RELEASE Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever Madrid (Spain) and Stirling (UK), May 28, 2019 – Algenex SL, a private [...]
Terveystalo Plc: Terveystalo Chief Executive Yrjö Närhinen has decided to step down, board has initiated a search for a successor
28/05/2019
Terveystalo Plc, Stock Exchange Release 28 May 2019 at 09:00 EEST Yrjö Närhinen (49), Chief Executive of Terveystalo Plc has decided to step down from his role. Board has initiated a search for a successor. Mr. Närhinen [...]
BrainStorm Senior Management to Present at BIO 2019
28/05/2019
- Chaim Lebovits, President & CEO Corporate Presentation, June 4, 2019 - - Ralph Kern MD, MHSc, Chief Medical Officer & Chief Operating Officer Round Table Panelist, June 4, 2019 - NEW YORK, May 28, 2019 (GLOBE [...]
Addex Annual General Meeting Scheduled for June 19, 2019
28/05/2019
Geneva, Switzerland, May 28, 2019 – Addex Therapeutics (SIX: ADXN) announced today that its Annual General Meeting will take place on Wednesday, June 19, 2019, at 11:00am at the Campus Biotech, Chemin des Mines 9, 1202 [...]
Nexstim NBS system sold to the Jewish General Hospital in Canada
28/05/2019
Press release, Helsinki, 28 May 2019 at 9.30 am (EET) Nexstim NBS system sold to the Jewish General Hospital in Canada Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") - the targeted neuromodulation company [...]
IBA signs contract to install proton therapy center in Italy
28/05/2019
Proteus ® ONE contract worth between EUR 35 and 40 million to IBA Louvain-La-Neuve, Belgium, 28 May 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the [...]
IBA signe un contrat pour installer un centre de protonthérapie en Italie
28/05/2019
Un contrat Proteus ® ONE* d’une valeur entre EUR 35 et 40 millions pour IBA Louvain-la-Neuve, Belgique, le 28 mai 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie [...]
Nanobiotix announces the launch of curadigm : a new nanotechnology platform for healthcare
28/05/2019
NANOBIOTIX ANNOUNCES THE LAUNCH OF CURADIGM: A NEW NANOTECHNOLOGY PLATFORM FOR HEALTHCARE Curadigm opens new growth pathways for Nanobiotix beyond oncology, built on the success and know-how established through the [...]
Nanobiotix annonce le lancement de Curadigm : une nouvelle plateforme de nanotechnologie dédiée à la santé
28/05/2019
NANOBIOTIX ANNONCE LE LANCEMENT DE CURADIGM : UNE NOUVELLE PLATEFORME DE NANOTECHNOLOGIE D É DI É E À LA SANT É Curadigm permettra d’ouvrir de nouvelles perspectives de croissance pour Nanobiotix dans le domaine de l’ [...]
Experts call for greater understanding of ‘bedwetting’ as a medical condition
28/05/2019
Bedwetting, also known as enuresis, is an uncontrollable leakage of urine while asleep 1 Bedwetting is common in children, with approximately 5–10% of 7-year-olds regularly wetting their beds and the problem may persist [...]
BC PharmaCare’s Biosimilars Initiative an important step towards improving patient access to safe and effective medicines
27/05/2019
Biosimilars Initiative implementation could contribute to significant cost savings for the BC healthcare system British Columbia’s initiative is the first-of-its-kind policy in Canada aimed at increasing the adoption of [...]
La Biosimilars Initiative du régime public d’assurance-médicaments de la Colombie-Britannique constitue une avancée importante pour l’amélioration de l’accès des patients à des médicaments sécuritaires et efficaces
27/05/2019
La mise en œuvre de l’initiative pourrait mener à des économies substantielles pour le système de soins de santé de la Colombie-Britannique L’initiative de la Colombie Britannique est la première politique de ce type au [...]
CB2 Insights to Host Q12019 Earnings Call on May 31, 2019
27/05/2019
TORONTO, May 27, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be hosting its [...]

Pages